BERSANI, Francesca

BERSANI, Francesca  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 38 (tempo di esecuzione: 0.033 secondi).
Titolo Data di pubblicazione Autore(i) File
A mix of two microRNAs with identical seed sequence has a synergistic rather than additive anti-cancer effect 2010 Francesca Bersani; Riccardo Taulli; Silvia Miretti; Valentina Foglizzo; Sharon Mazzero; Carola Ponzetto
Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors 2015 Flynn R.L.; Cox K.E.; Jeitany M.; Wakimoto H.; Bryll A.R.; Ganem N.J.; Bersani F.; Pineda J.R.; Suva M.L.; Benes C.H.; Haber D.A.; Boussin F.D.; Zou L.
An In vivo Model of Met-Driven Lymphoma as a Tool to Explore the Therapeutic Potential of Met Inhibitors 2008 P. ACCORNERO; G. LATTANZIO; T. MANGANO; R. CHIARLE; R. TAULLI; F. BERSANI; P.E. FORNI; S. MIRETTI; C. SCUOPPO; W. DASTRU; J. CHRISTENSEN; T. CREPALDI; C. PONZETTO
AR expression in breast cancer CTCs associates with bone metastases 2018 Aceto N.; Bardia A.; Wittner B.S.; Donaldson M.C.; O'Keefe R.; Engstrom A.; Bersani F.; Zheng Y.; Comaills V.; Niederhoffer K.; Zhu H.; Mackenzie O.; Shioda T.; Sgroi D.; Kapur R.; Ting D.T.; Moy B.; Ramaswamy S.; Toner M.; Haber D.A.; Maheswaran S.
Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models 2014 Bersani F.; Lee J.; Yu M.; Morris R.; Desai R.; Ramaswamy S.; Toner M.; Haber D.A.; Parekkadan B.
Bortezomib-mediated proteasome inhibition as a potential strategy for the treatment of rhabdomyosarcoma 2008 F. BERSANI; R. TAULLI; P. ACCORNERO; A. MOROTTI; S. MIRETTI; T. CREPALDI; C. PONZETTO
Capture and printing of fixed stromal cell membranes for bioactive display on PDMS surfaces 2013 Lee J.; Wang J.B.; Bersani F.; Parekkadan B.
Conditional activation of met in differentiated skeletal muscle induces atrophy 2007 CREPALDI T; BERSANI F; SCUOPPO C; ACCORNERO P; PRUNOTTO C; TAULLI R; FORNI PE; LEO C; CHIARLE R; GRIFFITHS J; GLASS DJ; PONZETTO C
Conditional expression of activated met in differentiated skeletal muscle induces atrophy 2006 CREPALDI T.; BERSANI F.; SCUOPPO C.; ACCORNERO P.; PRUNOTTO C.; TAULLI R.; FORNI P.; LEO C.; CHIARLE R.; GRIFFITHS J.; GLASS D.; PONZETTO C.
Conditional expression of hepatocyte growth factor in cardiac and skeletal muscle for regeneration studies 2006 Crepaldi T.; Bersani F.; Taulli R.; Forni P.; Sala V.; Scuoppo C.; Leo C.; Riess I.; Grinza A.; Ponzetto C.
Conditional expression of hepatocyte growth factor in cardiac and skeletal muscle for regeneration studies 2006 Crepaldi T.; Bersani F.; Taulli R.; Forni P.; Sala V.; Scuoppo C.; Leo C.; Riess I.; Grinza A.; Ponzetto C.
Conditional expression of the Met oncogene in skeletal muscle induces severe atrophy in mice 2005 T. CREPALDI; C. SCUOPPO; P. ACCORNERO; F. BERSANI; R. TAULLI; P. FORNI; C. PONZETTO.
Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma 2016 Francesca Bersani; Lingua, Marcello Francesco; Morena, Deborah; Foglizzo, Valentina; Miretti, Silvia; Lanzetti, Letizia; Carrà, Giovanna; Morotti, Alessandro; Ala, Ugo; Provero, Paolo; Chiarle, Roberto; Singer, Samuel; Ladanyi, Marc; Tuschl, Thomas; Ponzetto, Carola; Taulli, Riccardo
Differential expression of microRNA-206 in skeletal muscle of female Piedmontese and Friesian cattle 2011 Miretti S.; Martignani E.; Taulli R.; Bersani F.; Accornero P.; Baratta M.
Effect-based and chemical analytical methods to monitor estrogens under the European Water Framework Directive 2018 Konemann S.; Kase R.; Simon E.; Swart K.; Buchinger S.; Schlusener M.; Hollert H.; Escher B.I.; Werner I.; Ait-Aissa S.; Vermeirssen E.; Dulio V.; Valsecchi S.; Polesello S.; Behnisch P.; Javurkova B.; Perceval O.; Di Paolo C.; Olbrich D.; Sychrova E.; Schlichting R.; Leborgne L.; Clara M.; Scheffknecht C.; Marneffe Y.; Chalon C.; Tusil P.; Soldan P.; von Danwitz B.; Schwaiger J.; San Martin Becares M.I.; Bersani F.; Hilscherova K.; Reifferscheid G.; Ternes T.; Carere M.
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility 2014 Yu M.; Bardia A.; Aceto N.; Bersani F.; Madden M.W.; Donaldson M.C.; Desai R.; Zhu H.; Comaills V.; Zheng Z.; Wittner B.S.; Stojanov P.; Brachtel E.; Sgroi D.; Kapur R.; Shioda T.; Ting D.T.; Ramaswamy S.; Getz G.; Iafrate A.J.; Benes C.; Toner M.; Maheswaran S.; Haber D.A.
Failure to downregulate the BAF53a subunit of the SWI/SNF chromatin remodelling complex contributes to the differentiation block in rhabdomyosarcoma 2014 Taulli Riccardo; Foglizzo Valentina; Morena Deborah; Coda Davide; Ala Ugo; Bersani Francesca; Maestro Nicola; Ponzetto Carola
Future perspectives from lung cancer pre-clinical models: new treatments are coming? 2020 Bersani, Francesca; Morena, Deborah; Picca, Francesca; Morotti, Alessandro; Tabbò, Fabrizio; Bironzo, Paolo; Righi, Luisella; Taulli, Riccardo
Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes 2016 Deborah Morena; Maestro, Nicola; Bersani, Francesca; Forni, Paolo Emanuele; Lingua, Marcello Francesco; Foglizzo, Valentina; C´epanovic, Petar Sˇ; Miretti, Silvia; Morotti, Alessandro; Shern, Jack F; Khan, Javed; Ala, Ugo; Provero, Paolo; Sala, Valentina; Crepaldi, Tiziana; Gasparini, Patrizia; Casanova, Michela; Ferrari, Andrea; Sozzi, Gabriella; Chiarle, Roberto; Ponzetto, Carola; Taulli, Riccardo
The IGF2 intronic miR-483 selectively enhances transcription from IGF2 fetal promoters and enhances tumorigenesis 2013 Liu M.; Roth A.; Yu M.; Morris R.; Bersani F.; Rivera M.N.; Lu J.; Shioda T.; Vasudevan S.; Ramaswamy S.; Maheswaran S.; Diederichs S.; Haber D.A.